Andrew Hirsch
2017 - Agios Pharmaceuticals
In 2017, Andrew Hirsch earned a total compensation of $2.3M as Chief Financial Officer and Head of Corporate Development at Agios Pharmaceuticals, a 56% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $217,537 |
|---|---|
| Option Awards | $1,639,353 |
| Salary | $453,201 |
| Other | $9,964 |
| Total | $2,320,055 |
Hirsch received $1.6M in option awards, accounting for 71% of the total pay in 2017.
Hirsch also received $217.5K in non-equity incentive plan, $453.2K in salary and $10K in other compensation.
Rankings
In 2017, Andrew Hirsch's compensation ranked 4,798th out of 14,666 executives tracked by ExecPay. In other words, Hirsch earned more than 67.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,798 out of 14,666 | 67th |
Division Manufacturing | 1,701 out of 5,772 | 71st |
Major group Chemicals And Allied Products | 502 out of 2,075 | 76th |
Industry group Drugs | 387 out of 1,731 | 78th |
Industry Pharmaceutical Preparations | 307 out of 1,333 | 77th |
Source: SEC filing on April 18, 2018.
Hirsch's colleagues
We found four more compensation records of executives who worked with Andrew Hirsch at Agios Pharmaceuticals in 2017.